DCT

1:24-cv-00050

Novo Nordisk Inc v. Mylan Pharma Inc

General
Filed
01/12/24
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
40%
Defendant
Party
Attorney
No Attorneys